XTENT Announces Plan for NASDAQ Delisting and Filing of Certificate of Dissolution
MENLO PARK, Calif., Aug. 5 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT ) today announced that it has provided written notice to The NASDAQ Stock Market, Inc. ("NASDAQ") of its intention to voluntarily delist its common stock from the NASDAQ Global Market. The Company currently ...
Caraco Pharmaceutical Laboratories, Ltd. Announces Filing of Purported Class Action Lawsuits
DETROIT, July 23 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) announced that on July 17, 2009 and July 23, 2009, two purported federal securities class action lawsuits were filed in the United States District Court for the Eastern District of Michigan...
Nycomed Announces FDA Filing for Daxas(R) in COPD
ZURICH, July 20 /PRNewswire/ -- N y comed tod a y announced t h e su b mission of a N e w Dru g Application (NDA) to the US Food a n d Drug Administr a tion ( F DA) for Da xas (R) as a on c e-da...
Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product
CARY, N.C., July 15 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq: CRTX ), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that it has submi...
Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R)
MORRISTOWN, N.J., July 15 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida ("Watson"), has filed an Abbreviated New Drug Application (ANDA) with t...
KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10-K
ST. LOUIS, June 22 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) (the "Company") today announced that it received a letter from NYSE Regulation, Inc. (the "NYSE") on June 16, 2009 informing the Company that it is subject to certain procedures as specified in Section 802.01E...
Isolagen, Inc. Announces Filing of Voluntary Petition Under Chapter 11 of the Bankruptcy Code
Isolagen, Inc. Receives Delisting Notice from NYSE Amex
EXTON, Pa., June 16 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (NYSE Amex: ILE ) today announced that on June 15, 2009, the Company and Isolagen Technologies, Inc., the Company's wholly owned subsidiary, each filed a voluntary petiti...
FDA Accepts Final Section of NDA Filing for LUCASSIN(R)
- Priority Review Granted -
LEBANON, N.J., and CLINTON, N.J., June 12 /PRNewswire/ -- Orphan Therapeutics, LLC and Ikaria Holdings, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the final section of the New Drug Application (NDA) filing
seeking marketing a...
Schering-Plough Announces European Filing of SYCREST(R) (asenapine) for the Treatment of Schizophrenia and Bipolar I Disorder
KENILWORTH, N.J., June 2 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today announced that the European Medicines Agency (EMEA) has validated (accepted for review) the company's Marketing Authorization Application (MAA) for SYCREST(R) (asenapine) sublingual tablets for the ...
AIM Health Group Inc. reports largest quarterly profit since going public and announces filing of financial results for the three months ended March 31, 2009 on SEDAR
TORONTO, May 22 /PRNewswire-FirstCall/ - AIM Health Group Inc. ("AIM" or the "Company") (TSXV - AHG), a fully integrated health care company, announced today that its income for the three months ended March 31, 2009 (the "Quarter") increased to $271,835 from a loss of $32,194 in the same period in...
Filing in Medical Technology
Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
KENILWORTH, N.J., July 22 /PRNewswire-FirstCall/ -- Schering-Plough today announced that a New Drug Application (NDA) for a fixed-dose combination of mometasone furoate and formoterol fumarate has been filed in the United States and accepted for review by the U.S. Food and Drug Administration...
ALP Life Sciences, LLC Announces Nanoveson(TM) Patent Filing and Whitepaper Availability on Proposed Therapy for Non-Alcoholic Fatty Liver Disease (NAFLD) and Comorbid Diseases
BLACK MOUNTAIN, N.C., June 24 /PRNewswire/ -- ALP Life Sciences, LLC (Company) today announced the Nanoveson(TM) patent has been filed and the Nanoveson(TM) whitepaper is available at www.ALPLifeSciences.com/wp . After completing initial research, the Company is pursuing clinical trials an...
Micromet Receives Milestone Payment for Filing of the First Clinical Trial Application for MT203
BETHESDA, Md., April 2 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the filing
of the first clinical trial application (CTA) in Eur...
Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
ALLEGAN, Mich., March 17 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO ; TASE) today announced that its partner Cobrek Pharmaceuticals, Inc. has filed an Abbreviated New Drug Application (ANDA) for Clindamycin Phosphate Foam 1%, a generic version of Evoclin(R) Foam 1%. The Company bel...
REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted
CUPERTINO, Calif., Aug. 12 /PRNewswire-FirstCall/ -- DURECT Corporation
(Nasdaq: DRRX ) announced today that the US Food and Drug Administration
(FDA) has accepted the New Drug Application (NDA) of REMOXY(R) and granted
Priority Review. The FDA typically grants Priority Review to drug
Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
EAST SETAUKET, N.Y., Aug. 12 /PRNewswire-FirstCall/ -- Lixte
Biotechnology Holdings, Inc. (OTC Bulletin Board: LIXT) announced today
that it had filed a patent application for the use of compounds the company
is developing for treatment of brain tumors as potential treatments for
CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R)
September meeting to focus on use of Zevalin as consolidation therapy after remission induction in previously untreated patients with follicular lymphoma
SEATTLE, July 22 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) (Nasdaq and MTA: CTIC) announced toda...
Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
CORONA, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Watson
Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical
company, today announced that its New Drug Application (NDA) for silodosin,
a novel alpha(1)- adrenoreceptor antagonist, has been accepted for filing
by the U.S. Foo...
Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
Secures 10th U.S. Clinical Site
FORT LAUDERDALE, Fla., Nov. 27 /PRNewswire-FirstCall/ -- Imaging
Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS) a pioneer in laser
optical breast imaging, announced today that the Company has secured its
10th U.S. clinical site to parti...
Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
KENILWORTH, N.J., Nov. 26 /PRNewswire-FirstCall/ -- Schering-Plough
Corporation (NYSE: SGP ) today announced that the U.S. Food and Drug
Administration (FDA) recently accepted the filing
for review of the New Drug
Application (NDA) for asenapine, a fast-dissolving, sublingual tablet.
Filing in Medical Products
Shandon Plastic Block Filing Cabinet
Description: Plastic Block Filing
Cabinet is a durable, six-drawer unit that holds up to 1500 slides....
Shandon Cardboard Block Filing Cabinet
Description: Cardboard Block Filing
Cabinet is an economical solution for block storage needs....
Block Filing Cabinet
Description: Allows for the organized storage of blocks that have been embedded using: Tissue Cassettes, Biopsy Cassettes, Mesh Cassettes, Mega Cassettes, Processing/Embedding Cassettes and Embedding Rings....
Company:Electron Microscopy Sciences
Slide/Cassette Filing System
Description: Our moisture resistant, plastic covered corrugated boxes interlock to stack ten high, each supporting up to 500 lbs of overhead cassette and slide weight. Each box accommodates 2000 slides or 500 tissue blocks to meet your varied storage requirements. Come unassembled boxes require minimal storage ...
Company:Electron Microscopy Sciences
Shandon Modular Filing System
Description: Modular Specimen Filing
System has five cells that can hold either slides or tissue cassettes....
Tissue File Cases
Description:...ging and storage system. This file system incorporates the necessary features offering embedment block protection, simplified cataloging, reduction of filing
error and facilitation of retrieval. All of this while conserving space and being very affordable....
Company:Electron Microscopy Sciences
LabStack 14 Drawer Slide Cabinet
Description:... High-quality, epoxy-coated, stackable steel cabinets for the storage of microscope slides, slide filing
wallets, processing cassettes, tissue blocks, transparencies and A5 index cards....
Tissue-Tek® Lab Aid®
Description:... A slide filing
system, allows for the convenient storage and retrieval of microscope slides or transparencies. Requires only 48 cm x 48 cm (19 inches x 19 inches) of...
Company:Electron Microscopy Sciences
hippo Medical Billing
Description:... hippo is a medical billing program dealing with the clerical aspects of filing
claims based on the industry standard Health Insurance Claim Form, or CMS-1500. hippo is an application that works over the internet. This means...
Company:dotnet network, LLC
Description:...ystem includes scheduling, patient demographics, insurance company information, encounter preparation, claims development, paper and electronic claims filing
capabilities, electronic claims remittance, system reports, Report Star (optional) reporting system for custom reports, Superbill generation, Superbil...
Company:MedStar Systems, LLC.
Filing in Biological News
NTU professor discovers method to efficiently produce less toxic drugs using organic molecules
...lective' producing asymmetric synthesis that is desirable, for example, in synthesising certain drugs with chiral centers.
Professor Zhong is also filing
for another patent related to his findings on domino synthesis, where the production process of one of the leading anti-cholesterol drugs in the world...
Minnesota Counties Secure New Criminal Charging System With BIO-key(R) Fingerprint Biometrics
...dream of going back to paper. "It takes a little while to get used to it; once you do, it works beautifully," says Waldron. Leaders say the electronic filing
system significantly reduces the time it takes for a criminal complaint to move through the justice system. What used to take days could now take only...
ACLU -- Myriad Genetics lawsuit will become landmark case
... New Rochelle, NY, May 14, 2009The American Civil Liberties Union action in filing
a lawsuit yesterday against Myriad Genetics is going to lead to one of the most important legal battles in the history of biotechnology, asserts Gene...
It's for the birds
...evelop tools to help manage that change, especially for at-risk species."
The millions of hand-scribbled cards sit in row upon row of federal green filing
cabinets of ancient vintage in a modest and fittingly old office dating from before WWII. The cards contain almost all of what was known of bird distr...
Acorda Therapeutics submits new drug application for Fampridine-SR in multiple sclerosis
... its review within ten months from receipt of the submission.
"This NDA filing
is a major milestone for Acorda and our Fampridine-SR development program,"...idine-SR was consistent across Phase 2 and Phase 3 trials. Overall, the NDA filing
included more that 50 clinical studies of Fampridine-SR. The total exposure...
Markets of biodiversity and equity in trade: An illusion?
... remains indisputable. The term in fact encompasses many different notions: filing
of patents on applications or properties of plants collected in local commu...nt, disclosure or use of traditional knowledge for commercial ends, filing
of common names as trade names, agreements whose clauses or implementation ...
Solidus Networks, Inc. Seats New Board of Directors
...rector role only.
The Board is steering the Company through the voluntary filing
bankruptcy under Chapter 11, which occurred in mid-December. They are
ex...eing marketed for acquisition. Core
subsidiaries not part of the bankruptcy filing
include Loyalty Acquisition
(dba Capture Resource) and S&H Marketing Servic...
Deep treasure to be found in Oculina Bank
...Operated Vehicle (ROV), an undersea robot equipped with video and still cameras and a manipulator arm for gathering samples. Team members will also be filing
daily dispatches from the ship at www.at-sea.org.
One of the expedition's goals is to "ground truth," or verify, a newly produced high-resolution m...
Filing in Biological Technology
Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
VANCOUVER, July 23 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP) today filed a preliminary short form base shelf prospectus with the securities commissions of British Columbia and Ontario and a corresponding shelf registration statement on Form S-3 with the U...
Thoratec Announces Filing of PMA Seeking Destination Therapy Approval for HeartMate II(R)
PLEASANTON, Calif., April 20 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR ), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it has filed a PMA (Pre-Market Approval) supplement with the FDA seeki...
Advanced Life Sciences Announces Filing of Shelf Registration Statement
CHICAGO, April 8 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS ), a biopharmaceutical company developing cethromycin, a novel once-a-day antibiotic, to treat respiratory tract infections and to combat bioterror threats, announced today that it has filed a shelf re...
China Sky One Medical, Inc. Provides Update on Filing Form 10-K
HARBIN, China, April 7 /PRNewswire-Asia-FirstCall/ -- China Sky One
Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a
leading fully integrated pharmaceutical company producing
over-the-counter drugs in the People's Republic of China ("PRC"), today
announced that an ...
Cell Therapeutics Announces Filing of Form 10-K
SEATTLE, March 23 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that it has filed its annual report on Form 10-K for the year ended December 31, 2008. This filing
is available for review on CTI's website at www.CellTherapeutics.com , or on the Secu...
Victhom announces the filing of a patent application to address sudden unexplained death in epilepsy (SUDEP)
QUEBEC, Feb. 11 /PRNewswire-FirstCall/ - Victhom Human Bionics Inc., "Victhom" (TSX: VHB), announced today the filing
of a patent application for the detection and treatment of a physiological disorder that most likely leads to sudden unexplainable death in epileptic patients during seizure.
Advanced Life Sciences Announces Cethromycin NDA Accepted for Filing by FDA for the Treatment of Community Acquired Pneumonia
CHICAGO, Dec. 3 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings,
Inc. (Nasdaq: ADLS ), today announced that the U.S. Food and Drug
Administration (FDA) has accepted and filed the Company's New Drug Application
(NDA) for cethromycin, a novel once-a-day oral antibiotic, for the treatment...
Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules
FRAZER, Pa. and PHILADELPHIA, Oct. 21 /PRNewswire-FirstCall/ --
Cephalon, Inc. (Nasdaq: CEPH ) and Eurand NV (Nasdaq: EURX ) today announced
receipt of a Paragraph IV Certification Notice Letter on October 20, 2008
regarding an Abbreviated New Drug Application (ANDA) submitted to the U.S.
ULURU Inc. Announces the Filing of a 510k Submission With the FDA for Altrazeal(TM) Silver
ADDISON, Texas, Sept. 30 /PRNewswire-FirstCall/ -- ULURU Inc. (Amex:
ULU) today announced that it has filed a 510k application with the United
States Food and Drug Administration (FDA) for Altrazeal(TM) Silver.
Preclinical studies conducted to support the filing
have shown that
FDA Meeting Provides Green Light for Cell Therapeutics Submission of Supplemental Filing for Zevalin(R) Label Expansion
Supplemental Biologics License Application (sBLA) on track for Q4 Submission
SEATTLE, Sept. 22 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) (Nasdaq: CTICD and MTA: CTIC) announced today that following a
meeting with the U.S. Food and Drug Administr...
Filing in Biological Dictionary
...ool supplies. Find Our Best Deals for Lateral filing
Cabinet at NexTag.com. Save Big on Accessories for...ers, Electronics, Gadgets and More! Read Lateral filing
Cabinet Reviews. Pronunciation of lateral . l...selection of wood, metal, modern, and traditional filing
cabinets at the guaranteed lowest prices. Late...